Literature DB >> 30590493

Impact of individualized segmentation on diagnostic performance of quantitative positron emission tomography for haemodynamically significant coronary artery disease.

Michiel J Bom1, Stefan P Schumacher1, Roel S Driessen1, Pieter G Raijmakers2, Henk Everaars1, Pepijn A van Diemen1, Adriaan A Lammertsma2, Peter M van de Ven3, Albert C van Rossum1, Juhani Knuuti4, Maija Mäki4, Ibrahim Danad1, Paul Knaapen1.   

Abstract

AIMS: Despite high variability in coronary anatomy, quantitative positron emission tomography (PET) perfusion in coronary territories is traditionally calculated according to the American Heart Association (AHA) 17-segments model. This study aimed to assess the impact of individualized segmentation of myocardial segments on the diagnostic accuracy of hyperaemic myocardial blood flow (MBF) values for haemodynamically significant coronary artery disease (CAD). METHODS AND
RESULTS: Patients with suspected CAD (n = 204) underwent coronary computed tomography angiography (CCTA) and [15O]H2O PET followed by invasive coronary angiography with fractional flow reserve assessment of all major coronary arteries. Hyperaemic MBF per vascular territory was calculated using both standard segmentation according to the AHA model and individualized segmentation, in which CCTA was used to assign coronary arteries to PET perfusion territories. In 122 (59.8%) patients, one or more segments were redistributed after individualized segmentation. No differences in mean MBF values were seen between segmentation methods, except for a minor difference in hyperaemic MBF in the LCX territory (P = 0.001). These minor changes resulted in discordant PET-defined haemodynamically significant CAD between the two methods in only 5 (0.8%) vessels. The diagnostic value for detecting haemodynamically significant CAD did not differ between individualized and standard segmentation, with area under the curves of 0.79 and 0.78, respectively (P = 0.34).
CONCLUSIONS: Individualized segmentation using CCTA-derived coronary anatomy led to redistribution of standard myocardial segments in 60% of patients. However, this had little impact on [15O]H2O PET MBF values and diagnostic value for detecting haemodynamically significant CAD did not change. Therefore, clinical impact of individualized segmentation seems limited. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  coronary artery disease; ischaemia; myocardial perfusion; positron emission tomography; segmentation

Year:  2019        PMID: 30590493     DOI: 10.1093/ehjci/jey201

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  4 in total

1.  Diagnostic Value of Lesion-specific Measurement of Myocardial Blood Flow Using Hybrid PET/CT.

Authors:  Sang Geon Cho; Hyeon Sik Kim; Jae Yeong Cho; Ju Han Kim; Hee Seung Bom
Journal:  J Cardiovasc Imaging       Date:  2019-12-24

2.  Multi-constraints based deep learning model for automated segmentation and diagnosis of coronary artery disease in X-ray angiographic images.

Authors:  Mona Algarni; Abdulkader Al-Rezqi; Faisal Saeed; Abdullah Alsaeedi; Fahad Ghabban
Journal:  PeerJ Comput Sci       Date:  2022-06-03

3.  Viability and functional recovery after chronic total occlusion percutaneous coronary intervention.

Authors:  Stefan P Schumacher; Henk Everaars; Wijnand J Stuijfzand; Pepijn A van Diemen; Roel S Driessen; Michiel J Bom; Ruben W de Winter; Yvemarie B O Somsen; Jennifer W Huynh; Ramon B van Loon; Peter M van de Ven; Albert C van Rossum; Maksymilian P Opolski; Alexander Nap; Paul Knaapen
Journal:  Catheter Cardiovasc Interv       Date:  2021-07-30       Impact factor: 2.585

4.  Clinical Application of Lesion-specific Measurement of Myocardial Blood Flow in the Left Anterior Descending Artery Using Hybrid Positron Emission Tomography-computed Tomography.

Authors:  Ki Seok Choo
Journal:  J Cardiovasc Imaging       Date:  2020-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.